Condition
Influenza, Human clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Influenza, Human clinical trials that are recruiting, at sites in 9 countries (most in China (3), United States (3), Spain (1)). By phase: Phase 3 (4), Phase 1/2 (2), Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 9Countries
Newest Influenza, Human clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Influenza vaccine based on mRNA in adults 18-64 | Phase 3 | Glendale, Arizona and 11 other locations | Recruiting | Oct 1, 2026 |
| Baloxavir for preventing flu after exposure in household contacts | Phase 3 | Guangzhou, Guangdong and 7 other locations | Recruiting | Sep 18, 2026 |
| Influenza vaccine study for adults 65 and older | Phase 3 | Anniston, Alabama and 162 other locations | Recruiting | Sep 4, 2026 |
| Intrahospital flu vaccine for adults with high cardiovascular risk when admitted for ACS or heart failure | — | Cologne and 1 other locations | Recruiting | Jul 23, 2026 |
| Testing a new quadrivalent influenza vaccine for safety and effectiveness | Phase 1/2 | Shijiazhuang, Hebei | Recruiting | Feb 13, 2025 |
| Evaluating a new treatment to prevent severe COVID-19 complications | Phase 1/2 | Alcalá de Henares, Madrid and 2 other locations | Recruiting | Nov 12, 2024 |
| Evaluating GP681 tablets for high-risk influenza patients | Phase 3 | Chizhou | Recruiting | Aug 27, 2024 |
| Oral vaccine for COVID-19 and influenza | Phase 1 | Adelaide, South Australia | Recruiting | Apr 9, 2024 |
| Comparing antiviral treatments for early symptomatic influenza | Phase 2 | Minas Gerais and 3 other locations | Recruiting | Dec 13, 2022 |
| Understanding immune responses to influenza vaccination in healthy adults | Phase 4 | Philadelphia, Pennsylvania | Recruiting | Nov 5, 2021 |
All recruiting trials (10)
-
Influenza vaccine based on mRNA in adults 18-64
A vaccine made with mRNA is being tested in adults 18 to 64 to see if it triggers a good immune response and is safe.
-
Baloxavir for preventing flu after exposure in household contacts
A single dose of baloxavir marboxil is being tested to see if it prevents symptomatic, lab-confirmed influenza in people who live with someone who has flu symptoms.
-
Influenza vaccine study for adults 65 and older
A vaccine trial tests an investigational mRNA flu shot against a licensed flu vaccine in adults 65+ to see if it better prevents flu during the season.
-
Intrahospital flu vaccine for adults with high cardiovascular risk when admitted for ACS or heart failure
This study tests whether offering a flu vaccine at the bedside during a hospital stay, along with counseling, increases vaccination rates for adults with acute coronary syndrome or heart failure who are at high cardiovascular risk.
-
Testing a new quadrivalent influenza vaccine for safety and effectiveness
This study is testing a new flu vaccine to see if it's safe and effective for adults aged 18 and older.
-
Evaluating a new treatment to prevent severe COVID-19 complications
This study is testing a new treatment to see if it can help hospitalized COVID-19 patients avoid severe complications caused by inflammation.
-
Evaluating GP681 tablets for high-risk influenza patients
This study tests if a new tablet called GP681 can help people aged 12 and older who are at high risk for complications from the flu feel better compared to a placebo.
-
Oral vaccine for COVID-19 and influenza
This study is testing whether an oral vaccine for COVID-19 and influenza can boost immunity better than traditional shots, making it easier for people to get vaccinated.
-
Comparing antiviral treatments for early symptomatic influenza
This study is testing different antiviral medications to see which ones work best for people with early symptoms of the flu who are otherwise healthy.
-
Understanding immune responses to influenza vaccination in healthy adults
This study is testing how well the flu vaccine works in healthy adults of different ages to see if their immune responses vary based on when they were born.
Related topics
Quick answers
How many Influenza, Human clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in China (3 trials), United States (3 trials), Spain (1 trial), Brazil (1 trial), Laos (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 4, Phase 1/2: 2, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.